Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis.
D000107:Acetylation; D000328:Adult; D000974:Antibodies, Antinuclear; D000937:Antigen-Antibody Reactions; D001172:Arthritis, Rheumatoid / Q000175:diagnosis*; D001794:Blood Pressure; D004247:DNA / Q000097:blood; D003937:Diagnosis, Differential; D004342:Drug Hypersensitivity / Q000097:blood / Q000175:diagnosis* / Q000209:etiology / Q000276:immunology; D005260:Female; D005334:Fever / Q000139:chemically induced; D005500:Follow-Up Studies; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects* / Q000652:urine; D006973:Hypertension / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis*; D008297:Male; D011110:Polymorphism, Genetic; D012621:Seasons; D013577:Syndrome; D013997:Time Factors
D000974:Antibodies, Antinuclear; D006830:Hydralazine; D004247:DNA